Everolimus Treated Anti-RCC Current Reserch Progress

Everolimus is an orally administered inhibitor of the mammalian target of rapamycin(mTOR),which is commonly used in clinical to prevent renal and heart transplant rejection.In recent years,Everolimus has been found to have better effect on advanced renal cell carcinoma,and can be used for patients with RCC after failure of treatment with sunitinib or sorafenib.This paper mainly introduce the everolimus mechnisim of anti-cancer reserch and its applications.